Oral transmucosal drug delivery–current status and future prospects M Sattar, OM Sayed, ME Lane International journal of pharmaceutics 471 (1-2), 498-506, 2014 | 192 | 2014 |
Preparation, characterization and buccal permeation of naratriptan M Sattar, J Hadgraft, ME Lane International Journal of Pharmaceutics 493 (1-2), 146-151, 2015 | 17 | 2015 |
Chemical modification and characterization of chitosan for pharmaceutical applications MA Almualla, MN Mosa, M Sattar Egyptian Journal of Chemistry 64 (7), 3635-3649, 2021 | 9 | 2021 |
Use of buccal morphine in the management of pain in children with life-limiting conditions: Results of a laboratory study R McCulloch, M Sattar, EM Henderson, ME Lane, M Bluebond-Langner Palliative Medicine 32 (2), 554-558, 2018 | 9 | 2018 |
Formulation of metoprolol bilayer tablets as an oral modified release dosage form MS Jabbar, YI Khalil. Iraqi J Pharm Sci 19, 21-30, 2010 | 7 | 2010 |
Oral transmucosal delivery of naratriptan M Sattar, ME Lane International Journal of Pharmaceutics 514 (1), 263–269, 2016 | 5 | 2016 |
Formulation and in Vitro Evaluation of Valsartan Flash Tablet M Sattar, MA Alshawi, MN Mosa Systematic Reviews in Pharmacy 11 (10), 213-219, 2020 | 4 | 2020 |
Oral Transmucosal Drug Delivery M Sattar, ME Lane Drug Delivery Approaches: Perspectives from Pharmacokinetics and …, 2021 | 3 | 2021 |
Spectrophotometric Determination of Nitrofurantoin in its Bulk and Pharmaceutical Formulations KS Abd-Alrassol, M Sattar, MN Mosa Systematic Reviews in Pharmacy 11 (10), 243-251, 2020 | 2 | 2020 |
Effect of Disintegrants on Spironolactone Tablet Stability A Almiahi, NY Fareed, M Sattar, MA Alshawi, MN Mousa International Journal of Drug Delivery Technology 11 (3), 756-761, 2021 | 1* | 2021 |
Stability of Dexamethasone Oral Liquid Formulations MA ALSHAWI, N ADDAI, M SATTAR, MN MOUSA, BS ALABDULLAH International Journal of Pharmaceutical Research 13 (1), 5454-5463, 2021 | | 2021 |